Benazepril patente?

Here’s a concise overview:

- Benazepril (the ACE inhibitor sold as Lotensin) is covered by several patent families over the years.
- The primary patent covering the benazepril molecule itself has expired in many major markets (e.g., the US and EU), and generic benazepril is widely available.
- There may still be active patents in some jurisdictions for specific salt forms, formulations, or combination products (for example, benazepril in fixed-dose combinations like with another antihypertensive). Those can extend protection for particular products or dosages in those markets.

If you want current, jurisdiction-specific status, I can help look it up. Please tell me:
- Which country or region you’re interested in (e.g., US, EU, UK, India, etc.)
- Whether you care about the basic benazepril molecule patent or a specific product/formulation (e.g., a salt form, a fixed-dose combination like benazepril with amlodipine), and
- If you want only patent status or also related regulatory exclusivities.

I can guide you to the exact patent documents or check databases like Google Patents, USPTO Patent Center, Espacenet, or WIPO PATENTSCOPE for the latest status.